Clorox (NYSE:CLX) Price Target Lowered to $130.00 at Barclays

Clorox (NYSE:CLX) had its target price decreased by investment analysts at Barclays from $139.00 to $130.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has an “underweight” rating on the stock. Barclays‘s price objective suggests a potential downside of 19.17% from the company’s previous close.

CLX has been the subject of several other reports. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI reduced their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, DA Davidson raised their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $156.54.

Clorox Stock Performance

Shares of NYSE CLX traded up $0.37 during mid-day trading on Friday, hitting $160.84. The company had a trading volume of 179,639 shares, compared to its average volume of 880,273. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a market capitalization of $19.91 billion, a price-to-earnings ratio of 56.07, a P/E/G ratio of 2.90 and a beta of 0.42. The stock’s 50-day moving average price is $164.40 and its 200-day moving average price is $156.17.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the firm earned $0.49 EPS. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. On average, sell-side analysts forecast that Clorox will post 6.87 earnings per share for the current year.

Institutional Investors Weigh In On Clorox

A number of hedge funds and other institutional investors have recently bought and sold shares of CLX. Brooklyn Investment Group grew its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new stake in Clorox during the third quarter valued at about $27,000. Continuum Advisory LLC raised its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Quarry LP raised its holdings in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Clorox during the third quarter valued at approximately $48,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.